ALBERT BOURLA - 31 Dec 2024 Form 4 Insider Report for PFIZER INC (PFE)

Role
Chairman & CEO, Director
Signature
/s/ Shanice A. Reid, by power of atty., for Albert Bourla
Issuer symbol
PFE
Transactions as of
31 Dec 2024
Net transactions value
+$531
Form type
4
Filing time
03 Jan 2025, 09:49:42 UTC
Previous filing
17 Dec 2024
Next filing
15 Jan 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PFE Phantom Stock Units SSP Award $531 +20 +0% $26.53 690,585 31 Dec 2024 Common Stock 20 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each unit represents one phantom share of common stock.
F2 These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.